SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-024059
Filing Date
2021-02-16
Accepted
2021-02-16 16:20:52
Documents
2
Group Members
CHEUNG KA HOFRANCES ANNE ELIZABETH RICHARDGOLWYN CAPITAL APPRECIATION LTDJILL MARIE FRANKLINULTIMATE KEEN LTDWONG YUK LAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm216530d1_sc13da.htm SC 13D/A 170330
2 EXHIBIT 99.1 tm216530d1_ex99-1.htm EX-99.1 9435
  Complete submission text file 0001104659-21-024059.txt   181787
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88812 | Film No.: 21638867
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR, LE PRINCE DE GALLES 3-5 AVENUE DES CITRONNIERS O9 MC 98000
Business Address C/O THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR, LE PRINCE DE GALLES 3-5 AVENUE DES CITRONNIERS O9 MC 98000 011 377 97-97-47-37
Morningside Venture (VI) Investments Ltd (Filed by) CIK: 0001636810 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D6 | Fiscal Year End: 1231
Type: SC 13D/A